Hormone refractory prostate cancer and fibroblast growth factor receptor

Breast Cancer

Volumn 6, Issue 4, 1999, Pages 320-324

  Matsubara, Akio ^a   Yasumoto, Hiroaki ^a   Usui, Tsuguru ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Gene therapy; Growth factors; Hormone refractoriness; Prostate cancer

Indexed keywords

EID: 0013242665     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02966447     Document Type: Review

References (18)

1. Yan G, Fukabori Y, Nikolaropoulos S, et al: Heparinbinding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. Mol Endocrinol 6:2123-2128, 1992. (Pubitemid 23021561)
2. Sugimura Y, Foster BA, et al: Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int J Dev Biol 40:941-951, 1996. (Pubitemid 26387216)
3. Lu W, Luo Y, Kan M, et al: Fibroblast growth factor-10; A second candidate stromal to epithelial cell andromedin in prostate. J Biol Chem 274:12827-12834, 1999.
4. Yan G, Fukabori Y, McBride G, et al: Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 13:4513-4522, 1993. (Pubitemid 23220358)
5. Feng S, Wang F, Matsubara A, et al: Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res 57:5369-5378, 1997. (Pubitemid 27516376)
6. Yan G, McBride G, McKeehan WL: Exon skipping causes alteration of the COOH-terminus and deletion of the phospholipase C gamma 1 interaction site in the FGF receptor 2 kinase in normal prostate epithelial cells. Biochem Biophys Res Commun 194:512-518, 1993. (Pubitemid 23237965)
7. Wang F, Kan M, Xu J, et al: Ligand-specific structural domains in the fibroblast growth factor receptor. J Biol Chem 270:10222-10230, 1995.
8. McKeehan WL, Adams PS, Fast D: Different hormonal requirements for androgen-independent growth of normal and tumor epithelial cells from rat prostate. In Vitro Cell Devel Biol 23:147-152, 1987.
9. Mansson PE, Adams P, Kan M, et al: Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors. Cancer Res 49:2485-2494, 1989. (Pubitemid 19125583)
10. Isaacs JT: Development and characteristics of the available animal model systems for the study of prostate cancer. In: N Bruchovsky WA, Gardner MI, Resnick PP Karr, DS Coffey eds, Current Concepts and Approaches to the Study of Prostate Cancer, New York, Alan R. Liss, Inc, pp573-576, 1987.
11. Matsubara A, Kan M, Feng S, et al: Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2. Cancer Res 58:1509-1514, 1998. (Pubitemid 28193616)
12. Kan M, Shi EG, McKeehan WL: Identification and assay of fibroblast growth factor receptors. Methods Enzymol 198:158-171, 1991.
13. Ornitz DM, Xu J, Colvin JS, et al: Receptor specificity of the fibroblast growth factor family. J Biol Chem 271:15292-15297 1996. (Pubitemid 26195013)
14. Rabin SJ, Cleghon V, Kaplan DR: SNT, a differentiation-specific target of neurotrophic factor-induced tyrosine kinase activity in neurons and PC12 cells. Mol Cell Biol 13:2203-2213, 1993. (Pubitemid 23097699)
15. Wang JK, Xu H, Li HC, et al: Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras. Oncogene 13:721-729, 1996. (Pubitemid 26312899)
16. Ong SH, Goh KC, Lim YP, et al: SUCl-associated neurotrophic factor target (SNT) protein is a major FGF-stimulated tyrosine phosphorylated 90-kDa protein which binds to the SH2 domain of GRB2. Biochem Biophys Res Commun 225:1021-1026, 1996. (Pubitemid 26319220)
17. Su WC, Kitagawa M, Xue N, et al: Activation of Statl by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386:288-292, 1997. (Pubitemid 27142515)
18. Carstens RP, Eaton JV, Krigman HR, et al: Alternative splicing of fibloblast growth factor receptor 2 (FGF-R2) in human prostate cancer. Oncogene 15:3059-3065, 1997. (Pubitemid 28043485)